Dose Estimation for Studies of Acute Respiratory Effects
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To modify and expand an existing pharmacokinetic model for nasal dose as well as to develop a new model to estimate tracheobronchial dose of an active agent for each subject in a study of acute respiratory health effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 1992
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1992
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 1995
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedMay 13, 2016
May 1, 2000
May 25, 2000
May 12, 2016
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Related Publications (1)
Woskie SR, Eisen EE, Wegman DH, Hu X, Kriebel D. Worker sensitivity and reactivity: indicators of worker susceptibility to nasal irritation. Am J Ind Med. 1998 Dec;34(6):614-22. doi: 10.1002/(sici)1097-0274(199812)34:63.0.co;2-s.
PMID: 9816420BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
September 1, 1992
Study Completion
August 1, 1995
Last Updated
May 13, 2016
Record last verified: 2000-05